Reference
1. Andrade J, Khairy P, Dobrev D, Nattel S (2014) The clinical profile
and pathophysiology of atrial fibrillation: relationships among clinical
features, epidemiology, and mechanisms. Circulation research
114(9):1453-1468.
2. Simantirakis EN, Papakonstantinou PE, Kanoupakis E, et al. (2018)
Recurrence rate of atrial fibrillation after the first clinical episode:
A prospective evaluation using continuous cardiac rhythm monitoring.
Clin Cardiol 41(5):594-600.
3. Dorian P, Paquette M, Newman D, et al. (2002) Quality of life
improves with treatment in the Canadian Trial of Atrial Fibrillation.
American heart journal 143(6):984-990.
4. Mark DB, Anstrom KJ, Sheng S, et al. (2019) Effect of Catheter
Ablation vs Medical Therapy on Quality of Life Among Patients With
Atrial Fibrillation: The CABANA Randomized Clinical Trial. Jama
321(13):1275-1285.
5. January CT, Wann LS, Alpert JS, et al. (2014) 2014 AHA/ACC/HRS
guideline for the management of patients with atrial fibrillation:
executive summary: a report of the American College of
Cardiology/American Heart Association Task Force on practice guidelines
and the Heart Rhythm Society. Circulation 130(23):2071-2104.
6. Ghia KK, Chugh A, Good E, et al. (2009) A nationwide survey on the
prevalence of atrioesophageal fistula after left atrial radiofrequency
catheter ablation. Journal of interventional cardiac electrophysiology :
an international journal of arrhythmias and pacing 24(1):33-36.
7. Garg L, Garg J, Gupta N, et al. (2016) Gastrointestinal complications
associated with catheter ablation for atrial fibrillation. International
journal of cardiology 224:424-430.
8. Wilber DJ, Pappone C, Neuzil P, et al. (2010) Comparison of
antiarrhythmic drug therapy and radiofrequency catheter ablation in
patients with paroxysmal atrial fibrillation: a randomized controlled
trial. Jama 303(4):333-340.
9. Packer DL, Kowal RC, Wheelan KR, et al. (2013) Cryoballoon ablation
of pulmonary veins for paroxysmal atrial fibrillation: first results of
the North American Arctic Front (STOP AF) pivotal trial. J Am Coll
Cardiol 61(16):1713-1723.
10. Morillo CA, Verma A, Connolly SJ, et al. (2014) Radiofrequency
ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal
atrial fibrillation (RAAFT-2): a randomized trial. JAMA 311(7):692-700.
11. Cosedis Nielsen J, Johannessen A, Raatikainen P, et al. (2012)
Radiofrequency ablation as initial therapy in paroxysmal atrial
fibrillation. N Engl J Med 367(17):1587-1595.
12. Wazni OM, Marrouche NF, Martin DO, et al. (2005) Radiofrequency
ablation vs antiarrhythmic drugs as first-line treatment of symptomatic
atrial fibrillation: a randomized trial. JAMA 293(21):2634-2640.
13. Hakalahti A, Biancari F, Nielsen JC, Raatikainen MJ (2015)
Radiofrequency ablation vs. antiarrhythmic drug therapy as first line
treatment of symptomatic atrial fibrillation: systematic review and
meta-analysis. Europace 17(3):370-378.
14. Andrade JG, Wells GA, Deyell MW, et al. (2020) Cryoablation or Drug
Therapy for Initial Treatment of Atrial Fibrillation. N Engl J
Med;10.1056/NEJMoa2029980.
15. Wazni OM, Dandamudi G, Sood N, et al. (2020) Cryoballoon Ablation as
Initial Therapy for Atrial Fibrillation. N Engl J
Med;10.1056/NEJMoa2029554.
16. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007)
Practical methods for incorporating summary time-to-event data into
meta-analysis. Trials 8:16.
17. Higgins JP, Altman DG, Gotzsche PC, et al. (2011) The Cochrane
Collaboration’s tool for assessing risk of bias in randomised trials.
BMJ 343:d5928.
18. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials.
Control Clin Trials 7(3):177-188.
19. Sterne JA, Egger M (2001) Funnel plots for detecting bias in
meta-analysis: guidelines on choice of axis. J Clin Epidemiol
54(10):1046-1055.
20. Simmonds M (2015) Quantifying the risk of error when interpreting
funnel plots. Systematic reviews 4:24-24.
21. Debray TPA, Moons KGM, Riley RD (2018) Detecting small-study effects
and funnel plot asymmetry in meta-analysis of survival data: A
comparison of new and existing tests. Research synthesis methods
9(1):41-50.
22. Kuck KH, Brugada J, Furnkranz A, et al. (2016) Cryoballoon or
Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med
374(23):2235-2245.
Table 1: Study characteristics of included randomized controlled trials
Table 2: Basic characteristics of study participants
Table 3: Cochrane Collaboration tool to assess risk of bias for
randomized controlled trials
Table 4: Summary of adverse events
Fig. 1: PRISMA flow diagram.
Fig. 2: Forest plot of the included studies comparing arrhythmia-free
survival between ablation group and antiarrhythmic medication group; 2A:
Cryoablation, 2B: Radiofrequency ablation
Supplementary material 1: Search term